Autoimmune bullous diseases with skin and eye involvement: Cicatricial pemphigoid, pemphigus vulgaris, and pemphigus paraneoplastica.

[1]  O. Ceylan,et al.  An Uncommon Ocular Manifestation of Pemphigus Vulgaris: Conjunctival Mass , 2013, Ocular immunology and inflammation.

[2]  H. Koga,et al.  Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab , 2013, The Journal of dermatology.

[3]  A. Ahmed,et al.  Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature. , 2013, Journal of the American Academy of Dermatology.

[4]  M. Alsina-Gibert,et al.  Infliximab therapy failure in two patients with pemphigus vulgaris. , 2012, Journal of the American Academy of Dermatology.

[5]  K. Propert,et al.  Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients. , 2012, Archives of dermatology.

[6]  R. Casson,et al.  Autoimmune Bullous Diseases , 2012, Drugs.

[7]  D. Zillikens,et al.  Current therapy of the pemphigus group. , 2012, Clinics in dermatology.

[8]  I. Avisar,et al.  Multiple Conjunctival Papillomas of Eyelid Margins in Pemphigus vulgaris , 2011, Case reports in ophthalmological medicine.

[9]  O. Okamoto,et al.  Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: A case report and review of cases treated with rituximab , 2011, The Journal of dermatology.

[10]  D. Murrell,et al.  Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome). , 2011, Dermatologic clinics.

[11]  J. Pagani,et al.  Conjunctival Erosions Associated with Pemphigus Vulgaris , 2011, Optometry and vision science : official publication of the American Academy of Optometry.

[12]  D. Murrell,et al.  A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus. , 2011, Journal of the American Academy of Dermatology.

[13]  A. Kimball,et al.  A pilot study of etanercept treatment for pemphigus vulgaris. , 2010, Archives of dermatology.

[14]  A. Ahmed,et al.  Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report. , 2010, Ophthalmology.

[15]  N. Kozeis,et al.  Triamcinolone acetonide for rare ocular manifestations of pemphigus vulgaris: a case report , 2010, Clinical ophthalmology.

[16]  P. Bhat,et al.  Paraneoplastic conjunctival cicatrization: two different pathogenic types. , 2010, Ophthalmology.

[17]  J. Kempen,et al.  Mycophenolate mofetil for ocular inflammation. , 2010, American journal of ophthalmology.

[18]  A. Young,et al.  Paraneoplastic pemphigus: an uncommon cause of chronic cicatrising conjunctivitis , 2009, BMJ Case Reports.

[19]  J. Kempen,et al.  Azathioprine for ocular inflammatory diseases. , 2009, American journal of ophthalmology.

[20]  J. Carter,et al.  Successful treatment of pemphigus vulgaris with etanercept in four patients. , 2009, Journal of drugs in dermatology : JDD.

[21]  H. Mouquet,et al.  ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus. , 2009, Archives of dermatology.

[22]  N. Katoh,et al.  Brunsting–Perry cicatricial pemphigoid associated with autoantibodies to the C‐terminal domain of BP180 , 2008, The British journal of dermatology.

[23]  D. Jabs,et al.  Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy. , 2008, Ophthalmology.

[24]  D. Chu,et al.  Ocular manifestations of blistering diseases. , 2008, Immunology and allergy clinics of North America.

[25]  C. Bunce,et al.  Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes. , 2006, Ophthalmology.

[26]  C. Chams‐Davatchi,et al.  Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. , 2007, Journal of the American Academy of Dermatology.

[27]  K. Yancey,et al.  A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer. , 2007, Journal of dermatological science.

[28]  G. Palleschi,et al.  Ocular involvement in pemphigus. , 2007, American journal of ophthalmology.

[29]  T. Ruzicka,et al.  Mucous membrane pemphigoid: clinical aspects, immunopathological features and therapy. , 2007, European journal of dermatology : EJD.

[30]  S. Yun,et al.  Paraneoplastic pemphigus without an underlying neoplasm , 2007, The British journal of dermatology.

[31]  H. Gollnick,et al.  A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid. , 2006, Archives of dermatology.

[32]  H. Gürcan,et al.  Antigen specificity in subsets of mucous membrane pemphigoid. , 2006, The Journal of investigative dermatology.

[33]  Muna Ahmed,et al.  Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment , 2004, Progress in Retinal and Eye Research.

[34]  D. Wakefield,et al.  Methotrexate therapy for ocular cicatricial pemphigoid. , 2004, Ophthalmology.

[35]  S. Halevy,et al.  Severe Conjunctival and Eyelid Involvement in Pemphigus Vulgaris , 2004, International Ophthalmology.

[36]  D. Jabs,et al.  Mucous membrane pemphigoid and pseudopemphigoid. , 2004, Ophthalmology.

[37]  K. Harman,et al.  Guidelines for the management of pemphigus vulgaris , 2003, The British journal of dermatology.

[38]  S. Kazerounian,et al.  Paraneoplastic pemphigus in children and adolescents , 2002, The British journal of dermatology.

[39]  D. West,et al.  The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. , 2002, Archives of dermatology.

[40]  Y. Yamashina,et al.  Genotyping for HLA‐A, B and C alleles in Japanese patients with pemphigus: prevalence of Asian alleles of the HLA‐B15 family , 2002, The British journal of dermatology.

[41]  T. Coté,et al.  Anti-epiligrin cicatricial pemphigoid and relative risk for cancer , 2001, The Lancet.

[42]  J. Naeyaert,et al.  Bilateral Corneal Melting in a Patient with Paraneoplastic Pemphigus , 2001, Dermatology.

[43]  M. Hsu,et al.  Paraneoplastic pemphigus in association with a retroperitoneal Castleman's disease presenting with a lichen planus pemphigoides‐like eruption. A case report and review of literature , 2001, The British journal of dermatology.

[44]  P. Itin,et al.  Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL , 2001, American journal of hematology.

[45]  M. Pittelkow,et al.  Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. , 2001, Archives of dermatology.

[46]  P. Courville,et al.  Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. , 2000, Journal of the American Academy of Dermatology.

[47]  K. Yancey,et al.  Fab fragments directed against laminin 5 induce subepidermal blisters in neonatal mice. , 2000, Clinical immunology.

[48]  P. Amerio,et al.  In Vitro and In Vivo Expression of Interleukin-1α and Tumor Necrosis Factor-α mRNA in Pemphigus Vulgaris: Interleukin-1α and Tumor Necrosis Factor-α are Involved in Acantholysis , 2000 .

[49]  M. Amagai,et al.  The new pemphigus variants. , 1999, Journal of the American Academy of Dermatology.

[50]  Zhi Hong Wang,et al.  Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. , 1999, The Journal of clinical investigation.

[51]  T. Nishikawa,et al.  The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. , 1999, Journal of the American Academy of Dermatology.

[52]  T. Nishikawa,et al.  Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. , 1998, The Journal of clinical investigation.

[53]  Delpech,et al.  Paraneoplastic pemphigus associated with Hodgkin's disease , 1998, The British journal of dermatology.

[54]  V. Ruocco,et al.  Drug-induced pemphigus. , 1998, Clinics in dermatology.

[55]  C. De Simone,et al.  Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity. , 1997, European cytokine network.

[56]  S Miyagawa,et al.  HLA-DRB1*04 and DRB1*14 alleles are associated with susceptibility to pemphigus among Japanese. , 1997, The Journal of investigative dermatology.

[57]  E. Manche,et al.  Ocular Cicatricial Pemphigoid and Ocular Manifestations of Pemphigus Vulgaris , 1997, International ophthalmology clinics.

[58]  R. Good,et al.  A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[59]  N. Pelc,et al.  Paraneoplastic Pemphigus: An Autoimmune Mucocutaneous Disease Associated with Neoplasia , 1990 .

[60]  G. Varley,et al.  Conjunctival involvement in paraneoplastic pemphigus. , 1992, American journal of ophthalmology.

[61]  R. Folberg,et al.  Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma. , 1992, Ophthalmology.

[62]  A. Ahmed,et al.  Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Masayuki Amagai,et al.  Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion , 1991, Cell.

[64]  A. Ahmed,et al.  Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[65]  C. Foster,et al.  Systemic Chemotherapy for Ocular Cicatricial Pemphigoid , 1991, Cornea.

[66]  E. Hodak,et al.  Conjunctival involvement in pemphigus vulgaris: a clinical, histopathological and immunofluorescence study , 1990, The British journal of dermatology.

[67]  A. Ahmed,et al.  Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[68]  J. Bystryn.  Adjuvant therapy of pemphigus. , 1984, Archives of dermatology.

[69]  Stuart I. Brown,et al.  Immunosuppressive therapy in ocular cicatricial pemphigoid. , 1983, American journal of ophthalmology.

[70]  R. Laros,et al.  Transplacental transmission of pemphigus. , 1983, JAMA.

[71]  J. Voorhees,et al.  Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. , 1982, The New England journal of medicine.

[72]  L. Wilson,et al.  Immunosuppressive Therapy for Progressive Ocular Cicatncial Pemphigoid , 1982 .

[73]  H. Perry,et al.  Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. , 1982, Journal of the American Academy of Dermatology.

[74]  J. Voorhees,et al.  Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. , 1981, The Journal of clinical investigation.

[75]  S. I. Brown,et al.  Ocular cicatricial pemphigoid. , 1981, Ophthalmology.

[76]  H. Hönigsmann,et al.  Cicatricial Pemphigoid: Immunofluorescence Investigations , 1973 .